48 filings
10-Q
2024 Q1
NMRA
Neumora Therapeutics Inc.
Quarterly report
7 May 24
4:01pm
8-K
NMRA
Neumora Therapeutics Inc.
7 May 24
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
7:15am
DEFA14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Additional proxy soliciting materials
4:15pm
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
8-K
NMRA
Neumora Therapeutics Inc.
15 Apr 24
Other Events
6:46am
S-8
vha34bo7jjc6k90ws
7 Mar 24
Registration of securities for employees
4:34pm
10-K
9i1bcu
7 Mar 24
Annual report
4:05pm
8-K
njlr9goqh0q0
7 Mar 24
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023
7:08am
8-K
idbjv
8 Jan 24
Regulation FD Disclosure
8:32am
8-K
1ifmssp3vy j8l5xqro
28 Nov 23
Other Events
4:21pm
10-Q
pr6 pagbvti
1 Nov 23
Quarterly report
4:05pm
8-K
36ch4eborrche76z08i
1 Nov 23
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:01pm
S-8
wcxp1
19 Sep 23
Registration of securities for employees
9:57pm
8-K
fs10x 6gsv8mq39k
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
o4j3n3miqezz1vx9
18 Sep 23
Prospectus supplement with pricing info
4:12pm
EFFECT
1w5 p28cnjpdvoj7
18 Sep 23
Notice of effectiveness
12:15am
CERT
ikr5 ku2d
14 Sep 23
Certification of approval for exchange listing
2:03pm
SEC STAFF LETTER
hj033
14 Sep 23
SEC staff letter
12:00am
8-A12B
9jw1kl eefw1tw
13 Sep 23
Registration of securities on exchange
5:00pm
CORRESP
q95vhrb ro6xrf
12 Sep 23
Correspondence with SEC
12:00am